36 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
. TABLE OF CONTENTS 6
PART I Item 1. Business Overview POINT Biopharma Global Inc. is a next-generation radioligand company. Our mission … is to accelerate the discovery, development and global access to targeted radioligand therapies. In pursuit of this mission, we have built a platform
424B3
3r6 lg5s7l5rbekr
13 May 22
Prospectus supplement
8:18am
424B3
725njyp6r3 y4i
31 Mar 22
Prospectus supplement
11:42am
POS AM
j5xo9e3ox
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
EX-99.1
3jygu4 mib
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
pm0n5o1l
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.1
hzry7evu994xonx008l
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
iqg2 fzj6e
12 Nov 21
Prospectus supplement
8:41am
424B3
ppcz2vz1gh c4ryih1b
28 Sep 21
Prospectus supplement
9:07am
8-K
EX-99.1
dag 561gjd1d
28 Sep 21
Entry into a Material Definitive Agreement
8:53am